We are thrilled to announce that Gerry Chillé, our Chief Strategy and Innovation Officer, and Giovanni Gentile, Clinical Trial Manager, will be taking the stage at the SINdem4Juniors’ 10th Winter Seminar on Dementia and Neurodegenerative Disorders! This event is focused on recent advances in clinical and experimental research in the field of dementia and neurodegenerative disorders and will be held from February 23-25, 2023, in Bressanone, Italy.
As leaders of the Soturi project, Gerry and Giovanni will be presenting on how they are combining behavioral science principles, wearable technology, and an algorithm-based clinical decision support system to optimize and personalize treatment for people living with Parkinson’s disease (PD).
Newel Health is developing Soturi, in a partnership with Orion Pharmaceuticals, to become a cutting-edge digital therapeutic (DTx) solution that leverages wearable and digital technology to manage symptoms’ fluctuations, track medication usage, improve medication adherence and provide more accurate and objective data for healthcare professionals.
The team will have the 11AM CET slot of February 24th and will be on-site and eager to meet with other experts in the space to discuss potential collaborations on Soturi.
Attendees at the SINdem4Juniors’ 10th Winter Seminar on Dementia and Neurodegenerative Disorders can expect to hear from experts in the field of neurology about their experiences and findings in areas such as clinical management, neuropsychology and behavior, neuroimaging, neurophysiology, genetics, and epidemiology. The event provides a platform for the exchange of cutting-edge research and innovative ideas.
So, mark your calendars and make plans to attend. We look forward to seeing you there!
Neurologists interested in learning more from our presenters are welcome to connect with Gerry and Giovanni at the event or contact us directly by filling out the form below:
